Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SII Yellow Fever Vaccine in Healthy Infants
NCT05447377Phase 3Recruiting
- Sponsor
- Serum Institute of India
- Start
- Sep 2022
- Primary completion
- Jan 2024
- Modality
- Live Attenuated Vaccines
- Countries
- 2
01
Overview
A Phase 3 trial of 17D yellow fever vaccine in yellow fever, sponsored by Serum Institute of India. Started Sep 2022; status: recruiting.
02
Drugs
17D yellow fever vaccine
03
Conditions
yellow fever
Beyond the preview
Go deeper on NCT05447377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05447377.